|
http://www.abbs.info e-mail:abbs@sibs.ac.cn ISSN
0582-9879
ACTA BIOCHIMICA et
BIOPHYSICA SINICA 2003, 35(8): 702¨C706
CN 31-1300/Q |
Assessment
of the Escherichia coli Tat Protein Translocation Systemwith Fluorescent
Proteins
ZHANG
Ming1,2,3, PAN Ren-Rui1, YU Zeng-Liang1,WU Long-Fei2*
( 1 Key Lab of Ion Beam Bioengineering,
Institute of Plasma Physics, the Chinese Academy of Sciences, Hefei 230031,
China; 2 Laboratoire de Chimie Bact¨¦rienne,
UPR9043 CNRS, 31 chemin Joseph Aiguier, 13402 Marseille cedex 20, France; 3
College of Life Science, Anhui Agricultural University, Hefei 230036, China )
Abstract The possibility of using
fluorescent proteins as probes to study the twin-arginine translocation (Tat)
system was assessed in Escherichia coli. When fused to the twin-arginine signal
peptide of trimethylamine N-oxide reductase, the DsRed2 red fluorescent protein
from the Discosoma sp. was successfully synthesized and folded in E. coli
cells. However, RR-DsRed2 aggregated inside the cells. Therefore, although
DsRed2 has been engineered from DsRed for faster maturation and lower
non-specific aggregation, it is still not compatible with Tat-dependent
translocation. In contrast, the jellyfish green fluorescent protein (GFP) was
efficiently exported into periplasm even when the RR motif was changed to KR or
RK. These results show that GFP can be used as an efficient reporter protein to
study Tat system, but DsRed2 is not suitable for such purpose because of its
aggregation property. In addition, when the protein concentration was similar,
the fluorescence intensity of KR-GFP and RK-GFP decreased compared with RR-GFP,
which would suggest that the twin-arginine signal peptide is not only essential
for mediating protein translocation, but also important for the folding of
down-stream protein.
Key
words fluorescent protein; report
protein; Tat protein translocation; signal peptide; protein folding
________________________________________
Received:
April 7, 2003 Accepted:
May 20, 2003
This
work was supported by the grants from INCO Bursary (No. ICB1-CT-2000-80014),
and the Outstanding Overseas Chinese Scholars Fund of Chinese Academy of
Sciences (No. 2003-1-5)
*Corresponding
author: Tel, +33-491164517; Fax, +33-491718914; e-mail, wu@ibsm.cnrs-mrs.fr
ÀûÓÃÓ«¹âµ°°×¶Ô´ó³¦¸Ë¾úµ°°×ÖÊTatתÔËϵͳµÄÑо¿
ÕÅÃ÷1,2,3 ÅËÈÊÈð1 ÓàÔöÁÁ1 ÎâÁú·É2*
( 1Öйú¿ÆÑ§ÔºµÈÀë×ÓÌåÎïÀíÑо¿ËùÀë×ÓÊøÉúÎ﹤³ÌÖØµãʵÑéÊÒ, ºÏ·Ê 230031; 2·¨¹ú¹ú¼Ò¿ÆÑ§Ñо¿ÖÐÐÄϸ¾ú»¯Ñ§Ñо¿ÊÒ, ÂíÈü 13402 cedex 20; 3°²»Õũҵ´óѧÉúÃü¿ÆÑ§Ñ§Ôº, ºÏ·Ê
230036 )
ÕªÒª ̽ÌÖÁËÓ«¹âµ°°××÷Ϊ±¨¸æµ°°×ÓÃÓÚµ°°×ÖÊתÔËϵͳÑо¿µÄ¿ÉÐÐÐÔ, ½á¹û±íÃ÷º£¿ûºìɫӫ¹âµ°°×¾Û¼¯ÔÚϸ°ûÖÊÄÚ, ²»ÄÜתÔËÖÁÖÜÖʿռ䡣 ¶øË®Ä¸ÂÌɫӫ¹âµ°°×ÔÚTatÐźÅëĺÍTatתÔËøµÄ¹²Í¬×÷ÓÃÏÂ,
ÒÔÕÛµþÐÎʽתÔËÖÁÖÜÖʿռ䡣 ͨ¹ýÓ«¹â¶¨Á¿·ÖÎö±íÃ÷ÐźÅëı£ÊØÐòÁÐÖеÄË«¾«°±ËáÊDZ£Ö¤ÂÌɫӫ¹âµ°°×תÔ˼°×ªÔËЧÂÊËù±ØÐèµÄ, ÇÒµÚ¶þ¸ö¾«°±Ëá±ÈµÚÒ»¸ö¾«°±Ëá¸üÎªÖØÒª¡£ ͬʱ,
½ÒʾÁËTatÐźÅëÄÐèÒªÒ»¶¨µÄ¸ß¼¶½á¹¹²ÅÄÜÐÐʹ¹¦ÄÜ; TatÐźÅëIJ»½öÒýµ¼µ°°×ÖʵÄתÔË, ¶øÇÒÒ²²ÎÓëµ°°×ÖʵÄÕÛµþ¡£
Òò´Ë, ÂÌɫӫ¹âµ°°×ÊǷdz£ÀíÏëµÄ±¨¸æµ°°×, ¿ÉÓÃÓÚÑо¿Tatϵͳ,
µ«ÊǺ£¿ûºìɫӫ¹âµ°°×Ò×ÓÚ¾Û¼¯¶ø²»ÊʺÏÓÚ´ËÄ¿µÄ¡£
¹Ø¼ü´Ê Ó«¹âµ°°×; ±¨¸æµ°°×; TatתÔËϵͳ;
ÐźÅëÄ; µ°°×ÖÊÕÛµþ
ϸ¾úµ°°×ÖÊTatתÔËϵͳÊÇ1998ÄêÔڴ󳦸˾úÖз¢ÏÖµÄÒ»ÖÖµ°°×ÖÊתÔËϵͳ, Òò±»×ªÔ˵ĵ×ÎïÐźÅëÄÉϺ¬ÓÐË«¾«°±Ëá(RR)±£ÊØÐòÁкËÐÄS/T-R-R-x-F-L-K[1¡«9], ËùÒÔ³ÆÎªTat
(twin-arginine translocation)תÔËϵͳ¡£ ÕâЩµ×ÎïÊÇһЩÓëϸ¾úÑáÑõºôÎüºÍϸ¾ú·ÖÁÑÓйصÄø»òµ°°×ÖÊ, ËùÒÔTatתÔËϵͳÓëϸ¾úµÄÉúÃü»î¶¯ÓÐ×ÅÊ®·ÖÃÜÇеĹØÏµ¡£ µ×Îïµ°°×³ýº¬ÓÐË«¾«°±ËáÐźÅëÄ(TatÐźÅëÄ)ÕâÒ»ÌØÐÔÍâ, »¹ÒÔÕÛµþµÄÐÎʽתÔË,
δÕÛµþµÄÏß×´µ°°×ÖÊÔòͨ¹ýSecתÔËϵͳ¡£ ´ó³¦¸Ë¾úTatתÔËϵͳµÄ¹¦Äܵ¥Î»TatתÔËøÓÉÈýÖÖTatµ°°×(TatA¡¢
TatB ºÍTatC)×é³É¡£ µ°°×ÖÊÐòÁзÖÎö±íÃ÷Tatµ°°×¶¼ÊÇ´©Ä¤µ°°×, ¾ÃâÒß¹²³ÁµíʵÑé֤ʵÁËTatA¡¢ TatBºÍTatC¹²´æÓÚϸ°ûĤÉÏ, ·ÖÀëÁËTatABºÍTatABC¸´ºÏÌå[10¡«12]¡£ ²¢ÔÚÌåÍâ·´Ó¦ÌåϵÖÐ×é×°Á˾ßÓлîÐÔµÄTatABC¸´ºÏÌå[13]¡£
TatBºÍTatCÊÇTatתÔËøµÄÖØÒª³É·Ö,
½üÀ´µÄÑо¿»¹±íÃ÷TatCµÄ°±»ùËáÖÖÀàºÍ·Ö²¼¶ÔתÔ˹¦ÄÜÓÐ×ÅÖØÒªµÄÓ°Ïì[14¡«16]¡£ ÕâЩÑо¿½øÕ¹¶ÔTatתÔËϵͳµÄ½øÒ»²½Ñо¿ÎÞÒÉÓкܴóµÄ´Ù½ø×÷Óá£
×ÔTatתÔËϵͳ·¢ÏÖÒÔÀ´, ¶àÒÔÌìÈ»ÒÀ¿¿TatתÔËϵͳתÔ˵Äø×÷Ϊ±¨¸æµ°°×, Èç´ó³¦¸Ë¾úµÄÈý¼×°·»ù-N-Ñõ»¯ÎﻹÔø[TMAO (trimethylamine N-oxide) reductase,
TMAO»¹Ôø]¡¢
Ç⻯ø-2(hydrogenase-2)µÈÑáÑõºôÎüø¡£ Ò»°ãͨ¹ýø»îÐÔ»òµ°°×ÖÊÓ¡¼£µÈ·½Ê½À´²â¶¨Ã¸µÄתÔËÓë·ñºÍתÔ˵ĶàÉÙ, µ«ÕâЩָ±ê»áÊÜø»îÐԲⶨÌõ¼þ¼°²â¶¨µÄÃô¸ÐÐԵȵÄÓ°Ïì¡£ ΪÁ˽¨Á¢¸üΪֱ½Ó¡¢
·½±ãµÄ¼ì²âÊÖ¶Î, ³¢ÊÔÓú£¿ûºìɫӫ¹âµ°°×(DsRed2)ºÍˮĸÂÌɫӫ¹âµ°°×(GFP)×÷Ϊ±¨¸æµ°°×, ½«TMAO»¹ÔøµÄÐźÅëÄ(TorA-RR)»ùÒòÓëÓ«¹âµ°°×»ùÒòÖØ×éÀ´Ñо¿Ï¸¾úµ°°×ÖÊTatתÔËϵͳ¡£ ÓÉÓÚÓ«¹âµ°°×ÕýÈ·ÕÛµþºó²ÅÄÜÐγÉÓ«¹â[17], ËùÒԿɸù¾ÝÓ«¹âµÄÓÐÎ޺ͷֲ¼È·¶¨Ó«¹âµ°°×µÄÕÛµþºÍתÔË×´¿ö; ͨ¹ý¶¨Á¿²â¶¨Ó«¹âµÄÇ¿ÈõÈ·¶¨TatתÔËϵͳµÄתÔËЧÂÊ,
´Ó¶øÃ÷È·Ó°ÏìתÔ˵ÄÒòËØ¡£
±¾Ñо¿±íÃ÷,
Á¬½ÓÔÚTorA-RRÐźÅëÄÏÂÓεĺìɫӫ¹âµ°°×Ôڴ󳦸˾úÖÐËä¿ÉÕýÈ·ÕÛµþºó²úÉúºìɫӫ¹â, µ«²»ÄÜתÔËÖÁÖÜÖʿռ䡣 ¾Í¬Ñù´¦ÀíµÄÂÌɫӫ¹âµ°°×¿ÉÕýÈ·ÕÛµþ, ²¢ÒÔÕÛµþÐÎʽÔÚTatµ°°×µÄ²ÎÓëÏÂתÔËÖÁÖÜÖʿռ䡣 ½øÒ»²½ÒÔÀµ°±Ëá(K)²»Í¬³Ì¶ÈµØÈ¡´úÐźÅëÄÖеľ«°±ËáÐγÉеÄÐźÅëÄ(TorA-KR, TorA-RKºÍTorA-KK), ÒÔÑо¿¾«°±Ëá¶ÔÂÌɫӫ¹âµ°°×תÔ˵ÄÓ°Ïì¡£
·¢ÏÖתÔËЧÂÊÓëÈ¡´úµÄ¾«°±ËáλÖÃÓÐÒ»¶¨µÄÏà¹ØÐÔ¡£ ½Òʾ¾«°±ËáÊÇÂÌɫӫ¹âµ°°×¸ßЧÂÊתÔËËù±ØÐèµÄ, ¶øÇÒµÚ¶þ¸ö¾«°±Ëá±ÈµÚÒ»¸ö¾«°±Ëá¸üÖØÒª¡£
ÕâÖÖÒ»¼¶½á¹¹µÄ¸Ä±äµ¼Ö½鵼תÔ˹¦ÄܵĽµµÍ»òɥʧ, ˵Ã÷ÐźÅëÄÒ»¼¶½á¹¹µÄ±ä»¯¿ÉÄÜÓ°Ïì¸ß¼¶½á¹¹µÄÐγɼ°±»TatϵͳÓÐЧµØÊ¶±ð, ½ø¶øÓ°ÏìÆä¹¦ÄÜ¡£ ͬʱ, ÏÔʾTatÐźÅëĶԵ°°×ÖÊÕÛµþºÍתÔ˶¼ÓÐÖÁ¹ØÖØÒªµÄ×÷Óá£
1 ²ÄÁϺͷ½·¨(Materials
and Methods)
1.1 ²ÄÁÏ
1.1.1 ¾úÖêºÍÖÊÁ£ ʵÑé¾úÖêTG1(¦¤(lac-pro)supE
thi hsd¦¤5/ F¡¯traD36 proA+B+ lacZ¦¤M15)¡¢
MC4100A(F-¦¤(argF-lac)U169 araD139 rpsL150
thi flb5301 deoC1 ptsF25 relA1 ara+)¡¢
B1LKOA(ÈçͬMC4100A ¦¤tatC)¡¢
BODA(ÈçͬMC4100A ¦¤tatB)¡¢
ELV16A(ÈçͬMC4100A ¦¤tatA)ºÍCU164A(ÈçͬMC4100A secY39cs, zhd-33¡ËTn10)[18,19]¡£
ÖÊÁ£p-DsRed2(ampR, DsRed2)¹º×ÔClontech¹«Ë¾¡¢
pRR-DsRed2(ampR, DsRed2¿Ë¡ÓÚpRR-gfp)¡¢ pgfpmut2(ampR, gfp gene)[17]¡¢ pRR-colV (ampR, cvaC¿Ë¡ÓÚpBAD8730)[18]¡¢ pRR-gfp (ampR, gfp¿Ë¡ÓÚpRR-colV)¡¢
pRKgfp¡¢ pKRgfp¡¢ pKKgfp¡¢
pAR-gfp[18,19]¡£
1.1.2 ÅàÑø»ù ²ÉÓÃLuria-Bertani (LB)ÅàÑø»ù, ±ØÒªÊ±Ìí¼Ó°±ÜÐÇàÃ¹ËØ(100
mg/L)(Amp)ºÍ°¢À²®ÌÇ(2 g/L)(APA)»òÆÏÌÑÌÇ(2 g/L)(APG)¡£
1.1.3 Ö÷Òª»¯Ñ§ÊÔ¼Á ÏÞÖÆÐÔÄÚÇÐø¡¢ T4Á¬½Óø¡¢ ¾ÛºÏøµÈ¹º×ÔRoche Molecular Biochemicals¹«Ë¾¡£
1.2 ·½·¨
1.2.1 ÅàÑøÌõ¼þ ǰÅàÑøÈ¡µ¥Ò»¾úÂä½ÓÖÖÓÚ4¡«5
mL LB»òAPGÅàÑø»ùÖÐ, 37 ¡æ¡¢
120 r/minÕñµ´ÅàÑø¹ýÒ¹»òÖÁA600Ϊ0.6ʱ,
100±¶Ï¡Êͺó½øÐÐÀ©´óÅàÑø¡£
1.2.2 ¿¹°¢À²®ÌǾúÖêµÄɸѡ ½«´ý´¦Àí¾úÍ¿²¼ÓÚº¬Êïºì´Î¼×»ùÀ¶(EMB)ºÍ°¢À²®ÌǵÄLBƽ°åÅàÑø»ùÉÏ, 37 ¡æ¹ýÒ¹ÅàÑø,
ÌôÈ¡×ϺìÉ«µÄµ¥¾úÂä, ·ÖÀë´¿»¯¡£
1.2.3 ¿Ë¡ӫ¹âµ°°×»ùÒò Ϊ¿Ë¡ÂÌɫӫ¹âµ°°×»ùÒò, Éè¼ÆÒýÎïΪ£º
gfp up (5¡ä-aag aag gag ata taa cat gca
gca aag gag-3¡ä), gfp down (5¡ä-tga cca tga agc ttg cat gcc tgc-3¡ä), ²¢ÔÚÉÏÏÂÓηֱðÒýÈëÁËNheI,
pstIºÍHindIIIøÇÐλµã¡£ Ϊ¿Ë¡ºìɫӫ¹âµ°°×»ùÒò, Éè¼ÆÁËÒýÎ DsRed2 up (5¡ä-tcg cca cca tgg cta gct ccg aga acg
tca-3¡ä), DsRed2 down (5¡ä-cta tta ggc ttg act gca gac aag ttg
gta-3¡ä), ²¢ÔÚÉÏÏÂÓηֱðÒýÈëÁËNheI, NotIøÇÐλµã¡£ ÒÔÉÏÒýÎï¾ùÓÉMWG-Biotech France¹«Ë¾ºÏ³É¡£ ²ÉÓÃExpand high fidelity PCR
system (Roche Molecular Biochemicals)ÔÚÌݶÈPCRºÏ³ÉÒǺϳɡ£ øÇмø¶¨À©ÔöƬ¶Î¡£
1.2.4 À©ÔöƬ¶ÎµÄ»ùÒò¿Ë¡ºÍÐòÁзÖÎö ÂÌɫӫ¹âµ°°×»ùÒòPCR²úÎï¾´¿»¯ºó, ÓÃNheIºÍHindIIIøÇкó¿Ë¡µ½ÖÊÁ£pRR-colVÏàӦλµã¡£ ºìɫӫ¹âµ°°×»ùÒòPCR²úÎï¾´¿»¯ºó, ÓÃNheIºÍNotIøÇкó¿Ë¡µ½ÖÊÁ£pRR-gfpÏàӦλµã, Á¬½Óת»¯TG1ºó, ÔÚAPAƽ°åÉÏÅàÑø¹ýÒ¹, ÔÚ×ÏÍâµÆÏÂÑ¡Ôñ·¢Ó«¹âµÄ¾úÂä, ÌáÈ¡ÖÊÁ£, øÇмø¶¨, DNAÐòÁвⶨÓÉMWG-Biotech
France¹«Ë¾²â¶¨¡£
1.2.5 pRR-gfpºÍpRR-DsRed2ת»¯ ת»¯pRR-gfpºÍpRR-DsRed2µ½MC4100A¼°¸÷tat»ùÒòȱÏÝÖêB1LKOA¡¢
BODA¡¢ ELV16AºÍSecY»ùÒòȱÏÝÖêCU164AÖС£
ÏÔ΢¾µ¹Û²ìÓ«¹â·Ö²¼²¢ÓÃCCDÏà»ú(Color Cool Viw, Photomic Sciences)ÉãÏñ²¢´¦Àí(Image Pro-Plus software)¡£
1.2.6 ϸ°û¸÷×é·ÖµÄÖÆ±¸ ϸ°ûÅàÑøÈçǰ, Ìí¼Ó0.2%°¢À²®ÌÇÓÕµ¼Ó«¹âµ°°×»ùÒò±í´ï¡£ ÊÕ»ñϸ°û²ÉÓÃÈܾúø-EDTA-±ùË®ÉøÍ¸Ñ¹´¦Àí[3], »ñµÃϸ°ûÖÜÖʿռä³É·Ö,
ÔÙÓÃFrench Press·¨µÃµ½Ï¸°ûÖʳɷ֡£
1.2.7 µçÓ¾ 10%¾Û±ûÏ©õ£°·Äý½ºµçÓ¾40 mA¡¢
40 min¡£
1.2.8 ¶¨Á¿²â¶¨Ó«¹âµ°°×µÄÇ¿¶È ÖÆ±¸Ï¸°ûÖÜÖʿռäºÍϸ°ûÖʳɷÖ, ¾»îÐÔÄý½ºµçÓ¾ºó, ¶¨Á¿²â¶¨Ï¸°û²»Í¬×é·ÖÖеÄÓ«¹âÁ¿(Spex Fluorolog III Ó«¹âÒÇ)¡£
2 ½á¹û(Results)
2.1 ¿¹°¢À²®ÌǾúÖêµÄɸѡ
ÒòΪtorA-gfpÖØ×é»ùÒòµÄ±í´ïÊÜ¿ØÓÚ°¢À²®ÌÇÆô¶¯×Ó, µ«araDȱÏݾúÖê·Ö½â°¢À²®ÌÇ»á²úÉúÓꦵÄÖмä´úлÎï¡£
ÔÚEMB-°¢À²®ÌÇÆ½°åÉÏɸѡÁË¿¹°¢À²®ÌÇ´úлµÄ×ϺìÉ«MC4100A¡¢ B1LKOA¡¢
CU164A¡¢ BODAºÍELV16A¾úÖê¡£ ¸÷¾úÖêÔÚº¬°¢À²®ÌǵÄÅàÑø»ùÉÏÉú³¤Õý³£¡£
2.2 Ó«¹âµ°°×»ùÒòÀ©Ôö²úÎïµÄ¿Ë¡¼°ÐòÁзÖÎö
º£¿ûºìɫӫ¹âµ°°×»ùÒòºÍˮĸÂÌɫӫ¹âµ°°×»ùÒòµÄPCRÀ©Ôö²úÎï¾Ã¸ÇкóÓëÏàÓ¦ÔØÌåÁ¬½Ó, ¾°±ÜÐÇàÃ¹ËØ¿¹ÐԺͱíÐÍɸѡºó, ·Ö±ðÌáÈ¡ÖÊÁ£²¢Ã¸Çмø¶¨, µÃµ½¶þ¸öÓëÏàÓ¦Ó«¹âµ°°×»ùÒòƬ¶Î´óСÏàËÆµÄƬ¶Î(0.69 kbºÍ0.73
kb), ÐòÁвⶨµÄ½á¹û½øÒ»²½ËµÃ÷Ä¿µÄ»ùÒòÒѿˡÓÚÔØÌåÖС£ ÖØ×éÖÊÁ£·Ö±ðÃüÃûΪpRR-DsRed2ºÍpRR-gfp¡£
2.3 Ó«¹âµ°°×ÔÚ²»Í¬Ï¸°ûÖеķֲ¼
½«ËùµÃµÄÖØ×éÖÊÁ£pRR-gfpºÍpRR-DsRed2·Ö±ðת»¯MC4100A¡¢ CU164A¡¢
B1LKOA¡¢ BODAºÍELV16A¸÷¾ú,
µÃµ½ÁËһϵÁеÄת»¯×Ó¡£ ¾´¿»¯·ÖÀë,
ÅàÑøºóÌáÈ¡ÖÊÁ£, ·Ö±ðÓÃNheIºÍHindIIIøÇС¢ NheIºÍNotIøÇмø¶¨, È·¶¨º¬ÓÐÏàÓ¦µÄÓ«¹âµ°°×»ùÒò¡£
¾°¢À²®ÌÇÓÕµ¼ÅàÑø, Ó«¹âµ°°×»ùÒòÔÚ¸÷¾úÖêÖоùÄܱí´ï¡£ ÔÚMC4100A/pRR-DsRed2ºÍB1LKOA/pRR-DsRed2ϸ°ûÖÐÖ»Äܹ۲쵽ºìɫӫ¹âµã(ͼ1)¡£
´Ë½á¹û±íÃ÷ËäÈ»DsRed2ÈܽâÐÔ½ÏDsRedÓÐËùÌá¸ß,
µ«ÊǺìɫӫ¹âµ°°×ÈÔ¾Û¼¯ÔÚϸ°ûÄÚ²»Äܱ»ÊäËͳöÈ¥¡£ Óë´ËÏà·´,
ÔÚÒ°ÉúÐ;úMC4100A/pRR-gfpϸ°ûÍâΧÓÐÒ»Ã÷ÏÔµÄÂÌɫӫ¹â¹â»·, ¶øÔÚtat»ùÒòÍ»±äÖêELV16A/pRR-gfp(¦¤tatA)¡¢
BODA/pRR-gfp(¦¤tatB)ºÍB1LKOA/pRR-gfp(¦¤tatC)ÖÐ,
ÂÌɫӫ¹âÖ»ÊǾùÔÈ·Ö²¼ÔÚÕû¸öϸ°ûÖÐ, ÇÒϸ°û³É¶Ô»ò³Ê¶ÌÁ´ÏàÁ¬²»·ÖÀë(ͼ2)¡£

Fig.1 Synthesis and distribution of
red fluorescent protein fused to the TorA-RR signal peptide in the wild type
(WT) strain and the ¦¤tatC mutant

Fig.2 Synthesis and distribution of
green fluorescent protein fused to the TorA-RR signal peptide in the wild type
strains and the ¦¤tat mutants
2.4 ÂÌɫӫ¹âµ°°×µÄתÔË
ÖÆ±¸Ï¸°ûÖÜÖʿռäºÍϸ°ûÖÊÌáȡҺ, ½øÐлîÐÔ¾Û±ûÏ©õ£°·Äý½ºµçÓ¾¡£ ½á¹ûÏÔʾMC4100AºÍCU164A¾úÖêµÄϸ°ûÖÜÖʿռäÌáȡҺÓÐÂÌɫӫ¹âµ°°×Ìõ´ø; µ«¶ÔÓÚB1LKOAºÍBODA¾úÖêÖ»ÔÚϸ°ûÖÊÌáȡҺÖÐÓÐÓ«¹âµ°°×Ìõ´ø, ÔÚÖÜÖʿռäÌáȡҺÖÐûÓÐÓ«¹âµ°°×Ìõ´ø(ͼ3)¡£ ÔÚϸ°ûÖÊÌáȡҺÖÐÂÌɫӫ¹âµ°°×ÊÇÒÔ´øÓÐÐźÅëĵÄǰÌåÐÎʽ´æÔÚ, ¶øÔÚϸ°ûÖÜÖʿռäÖÐÓÉÓÚÂÌɫӫ¹âµ°°×תÔ˺óÐźÅëı»Çгý, ËùÒÔÂÌɫӫ¹âµ°°×µÄ·Ö×Ó´óСÓвîÒì¡£

Fig.3 Translocation of the green
fluorescent protein in the wild type strains and the tat mutants
Strains
were separated on 10% native polyacrylamide gels and inspected under UV lamp.
(A) Wild type strain (WT). (B) secY. (C) ¦¤tatC.
(D) ¦¤tatB. 1, fractions of cytoplasm; 2,
fractions of periplasm.
2.5 ÐźÅëÄÖÐË«¾«°±Ëá¶ÔÂÌɫӫ¹âµ°°×תÔ˵ÄÓ°Ïì
ͨ¹ýÓ«¹â·Ö¹â¹â¶È¼Æ²â¶¨Ï¸°ûÖÊÄÚ(ͼ4, °×É«¿é´ø)ºÍÖÜÖʿռäÖÐ(ºÚÉ«¿é´ø)µÄÂÌɫӫ¹âÇ¿¶È, ½á¹û±íÃ÷È¡´úÁ˱£ÊØÐòÁÐÖеIJ»Í¬Ë«¾«°±ËáÐγɵÄÐźÅëÄTorA-KK, TorA-KRºÍTorA-RK½µµÍÁËÓ«¹âµ°°×µÄתÔËЧÂÊ¡£
µÚ¶þλ¾«°±ËáµÄÈ¡´ú±ÈµÚһλ¾«°±ËáµÄÈ¡´úµÄ¸º×÷Óôó, Íêȫȡ´úÔò²»½éµ¼ÂÌɫӫ¹âµ°°×µÄתÔË¡£ ´ËÍâ,
TorA-KR, TorA-RKºÍTorA-KK×ÜÌåÓ«¹âÁ¿½ÏTorA-RR×ÜÌåÓ«¹âÁ¿Öð½¥ÓÐËùϽµ¡£

Fig.4 Effect of twin arginine motif
substitutions on the translocation of GFP in the wild type strain
Fluorescences
of GFP in the periplasm (¡ö)
and in the cytoplasm (¡õ)
were quantified by Spex Fluorolog III. The arbitrary units of fluorescence were
indicated.
3 ÌÖÂÛ(Discussion)
3.1 ×÷Ϊϸ¾úTatתÔËϵͳ±¨¸æµ°°×µÄÍâÔ´Ó«¹âµ°°×ÐÔÖÊÉÏÓвîÒì
ͨ¹ýʵÑéÖ¤Ã÷²»Í¬µÄÍâÔ´Ó«¹âµ°°×ÓÉÓÚÆä×ÔÉíÐÔÖʵIJîÒì, ÔÚ×÷Ϊϸ¾úTatתÔËϵͳµÄ±¨¸æµ°°×ʱ±íÏÖ³ö²»Í¬µÄ½á¹û¡£ ÔÚÒ°ÉúÐÍMC4100AºÍCU164A¾úÖêÖÐ,
ÂÌɫӫ¹âµ°°×¿ÉÒÔתÔËÖÁÖÜÖʿռäÒÔ³ÉÊìÐÎʽ´æÔÚ[ͼ3(A), (B)]¡£ ¶øÔÚ¸÷tat»ùÒòȱÏÝÖêB1LKOAºÍBODAÖÐÂÌɫӫ¹âµ°°×½öÒÔǰÌåµÄÐÎʽ´æÔÚÓÚϸ°ûÖÊÖÐ, ûÓÐתÔ˵½ÖÜÖʿռä[ͼ3(C), (D)], Õâ˵Ã÷ÂÌɫӫ¹âµ°°×Ôڴ󳦸˾úÖпÉÕýÈ·ÕÛµþ, ²¢ÔÚtatBºÍtatC»ùÒò²úÎïµÄ¹²Í¬²ÎÓëÏÂתÔË, ÓëSecϵͳÎ޹ء£ Òò¶ø¿É×÷ΪTatתÔËϵͳµÄ±¨¸æµ°°×[19]¡£ º£¿ûºìɫӫ¹âµ°°×Ëä¿ÉÕýÈ·ÕÛµþ·¢³öºìɫӫ¹â, µ«²»ÄÜתÔË¡£ »îÐÔÄý½ºµçӾʵÑé±íÃ÷, ÔÚMC4100A¾úÖêºÍtat»ùÒòȱÏÝÖêϸ°ûÖʳéÌáÒºÖоùÓкìɫӫ¹âµ°°×Ìõ´ø, µ«ÖÜÖʿռä³éÌáÒºÖÐÎÞºìɫӫ¹âµ°°×Ìõ´ø(ͼδÏÔʾ), ÕâÒ»½á¹ûÓëÏÔ΢¾µ¹Û²ì½á¹ûÒ»Ö¡£
ÂÌÉ«ºÍºìɫӫ¹âµ°°×ÐòÁоßÓÐ23%ͬһÐÔ, ·Ö×Ó´óС½üËÆ(·Ö×ÓÁ¿·Ö±ðΪ27 kDºÍ28
kD), Èýά¿Õ¼ä½á¹¹Ïàͬ[20]¡£
ÓÈÆäÖØÒªµÄÊÇÁ½ÕßÓ«¹â»ùÍŶ¼ÊÇÔÚµ°°×ÕÛµþºó, ÓÉ3¸ö°±»ùËáͨ¹ý×ÔÎÒ´ß»¯Ñõ»¯·´Ó¦Ðγɻ·×´½á¹¹¶ø²úÉúµÄ¡£ ÂÌɫӫ¹âµ°°×ÒÔµ¥ÌåÐÎʽ´æÔÚ, ¶øºìɫӫ¹âµ°°×ÔòΪËľÛÌå²¢Ò×ÓÚ¾Û¼¯[21], ÒÔÖÂÓÚÔÚ°ûÄÚ¾ÛºÏÐγɴó·Ö×Ó¶ø²»ÄÜתÔ˶ø»ý¾ÛÔÚϸ°ûÖÊÖС£ ´Ó¶øÒ²ËµÃ÷ÁËתÔËͨµÀµÄ´óСÊÇÒ»¶¨µÄ, ²»ÔÊÐíÌ«´óµÄ·Ö×Óͨ¹ý¡£ ¹Êºìɫӫ¹âµ°°×²»ÒË×÷Ϊ±¨¸æµ°°×¡£
3.2 Ë«¾«°±ËáÊÇÂÌɫӫ¹âµ°°×¸ßЧÂÊתÔËËù±ØÐèµÄ
ÔçÆÚµÄÑо¿±íÃ÷TatÐźÅëĵÄË«¾«°±Ëá¶Ôµ°°×ÖÊ×